Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oocyte Activation: Revised or Initial Activated Gamete Treatment (AGT) Technique, Which is Better?! A Sibling-oocytes-split Design and Case Series of Chemical Pregnancies

NCT05113238 is registered in ClinicalTrials.gov with Royal Fertility Center, Egypt as lead sponsor.

NCT NCT05113238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05113238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oocyte Activation: Revised or Initial Activated Gamete Treatment (AGT) Technique, Which is Better?! A Sibling-oocytes-split Design and Case Series of Chemical Pregnancies
Lead sponsor
Royal Fertility Center, Egypt
Phase
Not applicable
Overall status
Completed
Start date
October 15, 2021
Completion date
December 30, 2021
Enrollment
222 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

assisted reproductive technology